Relevant experimental studies confirmed that serpine1 expression levels were elevated in mouse models and significantly upregulated in the coronary artery disease (CAL) cohort [20], providing molecular substantiation for 2,4-D-induced cerebrovascular complications. This evidence concerns the gene SERPINE1 and coronary artery disorder.